We aim to evaluate the incidence of atrial fibrillation (AF) in a large real‐world cohort of patients implanted with an insertable cardiac monitor (ICM) who had a clinical history of… Click to show full abstract
We aim to evaluate the incidence of atrial fibrillation (AF) in a large real‐world cohort of patients implanted with an insertable cardiac monitor (ICM) who had a clinical history of symptomatic heart failure (HF) with reduced or preserved left ventricular ejection fraction (LVEF).
               
Click one of the above tabs to view related content.